Stemson Therapeutics is a preclinical stage company developing a novel cell therapy to regenerate hair follicles to treat Alopecia and various forms of hair loss. Stemson was founded in 2018 based on a unique Induced Pluripotent Stem Cell approach to generate the cell types required to initiate hair growth, which was developed by Stemson cofounder, Alexey Terskikh, PhD, in his lab at the Sanford Burnham Prebys Medical Discovery Institute. The technology has the ability to generate a new supply of hair follicles for patients in need, a capability no other hair loss solution can deliver. The company secured an initial seed funding of $7.5M in 2019 led by Allergan, an Abbvie company, and Fortunis Capital. Stemson Therapeutics is headquartered in San Diego, CA. For more information, please visit www.stemsontx.com.